## APH: Amphenol Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -0.4% below STRENGTH zone (3.0-6.0%); PEG 1.95 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($131.82)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-13 | Barclays | $143 | $120 | +19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-13 | Barclays | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 6 ($17.45M) |
| Sells | 7 ($16.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (-10.9%)
- Blackrock Inc.: 8.2% (+6.7%)
- FMR, LLC: 8.1% (-8.1%)
- State Street Corpora: 4.6% (+1.2%)
- Price (T.Rowe) Assoc: 3.6% (+5.8%)

### Key Risks

1. Heavy insider selling: $17M sold (7 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.95 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 35%, ROA 14%, margin 18%). Balance sheet: strong liquidity (2.1x), $1.2B free cash flow. Analyst sentiment positive (1 raises, avg +19%). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $171.4B |
| Beta | 1.19 |
| 52W Range | $56.45 - $144.37 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.95 |
| Forward P/E | 35.0 |
| Current P/E | 42.3 |
| YoY Growth | 21.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 1.0% to -0.4% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.4pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.44% (CS: 51) | Neutral |
| RSI_14 | 56.4 | Neutral |
| MACD Histogram | -0.04 | Bearish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.053x | Above |
| vs SMA200 | 1.387x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $140.06
- **Stop Loss:** $131.82 (5.9% risk)
- **Target:** $148.30 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 145
- **Position Value:** $20,308.70
- **Portfolio %:** 20.31%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-01-28 (Est: $0.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.80 | $0.93 | +16.5% |
| 2025Q2 | $0.67 | $0.81 | +21.7% |
| 2025Q1 | $0.52 | $0.63 | +21.0% |
| 2024Q4 | $0.50 | $0.55 | +9.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*